Swinburn B, Egger G, Raza F. Dissecting obesogenic environments: the development and application of a framework for identifying and prioritizing environmental interventions for obesity. Prev Med. 1999;29(6):563–70.
Article CAS PubMed Google Scholar
Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, et al. The global obesity pandemic: shaped by global drivers and local environments. The Lancet. 2011;378(9793):804–14.
Bedogni G, Nobili V, Tiribelli C. Epidemiology of fatty liver: an update. World J Gastroenterol: WJG. 2014;20(27):9050.
PubMed PubMed Central Google Scholar
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–23.
Arefhosseini S, Ebrahimi-Mameghani M, Najafipour F, Tutunchi H. Non-alcoholic fatty liver disease across endocrinopathies: interaction with sex hormones. Front Endocrinol. 2022;13:1032361.
Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, et al. Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults. Clin Gastroenterol Hepatol. 2022;20(3):e573–82.
Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.
Article CAS PubMed Google Scholar
Marchisello S, Di Pino A, Scicali R, Urbano F, Piro S, Purrello F, et al. Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview. Int J Mol Sci. 2019;20(8):1948.
Article CAS PubMed PubMed Central Google Scholar
Marušić M, Paić M, Knobloch M, Liberati Pršo A-M. NAFLD, insulin resistance, and diabetes mellitus type 2. Can J Gastroenterol Hepatol. 2021;2021:6613827.
Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, et al. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21(5):739–46.
Article CAS PubMed Google Scholar
Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672–82.
Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol: WJG. 2010;16(38):4773.
Article PubMed PubMed Central Google Scholar
Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, et al. From NAFLD to MAFLD: implications of a premature change in terminology. Hepatology. 2021;73(3):1194–8.
Russo S, Kwiatkowski M, Govorukhina N, Bischoff R, Melgert BN. Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites. Front Immunol. 2021;12:746151.
Article CAS PubMed PubMed Central Google Scholar
Suzuki K. Chronic inflammation as an immunological abnormality and effectiveness of exercise. Biomolecules. 2019;9(6):223.
Article CAS PubMed PubMed Central Google Scholar
Liver EAftSoT, Diabetes EAftSo. EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Obesity facts. 2016;9(2):65–90.
Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328–57.
Palacka P, Kucharska J, Murin J, Dostalova K, Okkelova A, Cizova M, et al. Complementary therapy in diabetic patients with chronic complications: a pilot study. Bratisl Lek Listy. 2010;111(4):205–11.
Hadi V, Pahlavani N, Malekahmadi M, Nattagh-Eshtivani E, Navashenaq JG, Hadi S, et al. Nigella sativa in controlling Type 2 diabetes, cardiovascular, and rheumatoid arthritis diseases: Molecular aspects. J Res Med Sci: The Off Jf Isfahan Univ Med Sci. 2021;26:20.
Pahlavani N, Roudi F, Zakerian M, Ferns GA, Navashenaq JG, Mashkouri A, et al. Possible molecular mechanisms of glucose-lowering activities of Momordica charantia (karela) in diabetes. J Cell Biochem. 2019;120(7):10921–9.
Article CAS PubMed Google Scholar
Malekahmadi M, Moradi Moghaddam O, Islam SMS, Tanha K, Nematy M, Pahlavani N, et al. Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: a randomized clinical trial protocol. Trials. 2020;21(1):1–9.
Pahlavani N, Sedaghat A, Moghaddam AB, Kiapey SSM, Navashenaq JG, Jarahi L, et al. Effects of propolis and melatonin on oxidative stress, inflammation, and clinical status in patients with primary sepsis: study protocol and review on previous studies. Clin Nutr ESPEN. 2019;33:125–31.
Pahlavani N, Rostami D, Ebrahimi F, Azizi-Soleiman F. Nuts effects in chronic disease and relationship between walnuts and satiety: review on the available evidence. Obes Med. 2020;17: 100173.
Salvoza N, Giraudi PJ, Tiribelli C, Rosso N. Natural compounds for counteracting nonalcoholic fatty liver disease (NAFLD): advantages and limitations of the suggested candidates. Int J Mol Sci. 2022;23(5):2764.
Article CAS PubMed PubMed Central Google Scholar
Parra-Vargas M, Rodriguez-Echevarria R, Jimenez-Chillaron JC. Nutritional approaches for the management of nonalcoholic fatty liver disease: an evidence-based review. Nutrients. 2020;12(12):3860.
Article CAS PubMed PubMed Central Google Scholar
Mirmiran P, Amirhamidi Z, Ejtahed H-S, Bahadoran Z, Azizi F. Relationship between diet and non-alcoholic fatty liver disease: a review article. Iran J Public Health. 2017;46(8):1007.
PubMed PubMed Central Google Scholar
Kalafati I-P, Borsa D, Dimitriou M, Revenas K, Kokkinos A, Dedoussis GV. Dietary patterns and non-alcoholic fatty liver disease in a Greek case–control study. Nutrition. 2019;61:105–10.
Article CAS PubMed Google Scholar
Zelber-Sagi S, Ivancovsky-Wajcman D, Isakov NF, Webb M, Orenstein D, Shibolet O, et al. High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. J Hepatol. 2018;68(6):1239–46.
Article CAS PubMed Google Scholar
He K, Li Y, Guo X, Zhong L, Tang S. Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Br J Nutr. 2020;124(1):1–13.
Article CAS PubMed PubMed Central Google Scholar
Harsha DW, Lin P-H, Obarzanek E, Karanja NM, Moore TJ, Caballero B, et al. Dietary Approaches to Stop Hypertension: a summary of study results. J Am Diet Assoc. 1999;99(8):S35–9.
Article CAS PubMed Google Scholar
Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Rahelić D, Kahleová H, et al. DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients. 2019;11(2):338.
Article CAS PubMed PubMed Central Google Scholar
Pahlavani N, Khayyatzadeh SS, Banazadeh V, Bagherniya M, Tayefi M, Eslami S, et al. Adherence to a dietary approach to stop hypertension (DASH)-style in relation to daytime sleepiness. Nat Sci Sleep. 2020;12:325.
Article PubMed PubMed Central Google Scholar
Valipour G, Esmaillzadeh A, Azadbakht L, Afshar H, Hassanzadeh A, Adibi P. Adherence to the DASH diet in relation to psychological profile of Iranian adults. Eur J Nutr. 2017;56(1):309–20.
Article CAS PubMed Google Scholar
Conlin PR, Chow D, Miller ER, Svetkey LP, Lin P-H, Harsha DW, et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens. 2000;13(9):949–55.
Article CAS PubMed Google Scholar
Lin P-H, Aickin M, Champagne C, Craddick S, Sacks FM, McCarron P, et al. Food group sources of nutrients in the dietary patterns of the DASH-Sodium trial. J Am Diet Assoc. 2003;103(4):488–96.
Watzinger C, Nonnenmacher T, Grafetstätter M, Sowah SA, Ulrich CM, Kauczor H-U, et al. Dietary factors in relation to liver fat content: a cross-sectional study. Nutrients. 2020;12(3):825.
Article CAS PubMed PubMed Central Google Scholar
Hekmatdoost A, Shamsipour A, Meibodi M, Gheibizadeh N, Eslamparast T, Poustchi H. Adherence to the dietary approaches to stop hypertension (DASH) and risk of nonalcoholic fatty liver disease. Int J Food Sci Nutr. 2016;67(8):1024–9.
Article CAS PubMed Google Scholar
Maskarinec G, Lim U, Jacobs S, Monroe KR, Ernst T, Buchthal SD, et al. Diet quality in midadulthood predicts visceral adiposity and liver fatness in older ages: the Multiethnic Cohort Study. Obesity. 2017;25(8):1442–50.
留言 (0)